Respiratory Research,
Год журнала:
2023,
Номер
24(1)
Опубликована: Окт. 12, 2023
Although
COVID-19
vaccines
and
their
booster
regimens
protect
against
symptomatic
infections
severe
outcomes,
there
is
limited
evidence
about
protection
asymptomatic
in
real-world
settings,
particularly
when
considering
that
the
majority
of
SARS-CoV-2
Omicron
were
asymptomatic.
We
aimed
to
assess
effectiveness
dose
inactivated
mainland
China,
i.e.,
Sinopharm
(BBIBP-CorV)
Sinovac
(CoronaVac),
infection
an
BA.5
seeded
epidemic.Based
on
infection-naive
but
highly
vaccinated
population
Urumqi,
study
cohort
comprised
all
37,628
adults
who
had
a
contact
history
with
individuals
having
infections,
close
contacts,
between
August
1
September
7,
2022.
To
actively
detect
RT-PCR
tests
performed
by
local
authorities
daily
basis
for
testing-positive
status
was
considered
laboratory-confirmed
outcome.
The
contacts
matched
at
ratio
1:5
fully
(i.e.,
2
doses)
groups
3
according
sex,
age
strata,
calendar
date,
settings.
Multivariate
conditional
logistic
regression
models
adopted
estimate
marginal
after
adjusting
confounding
variables.
Subgroup
analyses
vaccine
(VE)
different
strata
age,
time
lag
from
last
exposure,
vaccination
source
case.
Kaplan-Meier
curves
employed
visualize
follow-up
process
testing
outcomes
among
subgroups
cohort.Before
matching,
37,099
adult
eligible
enrolment.
After
2-dose
3-dose
included
3317
16,051
proportions
1.03%
0.62%
groups,
respectively.
estimated
adjusted
versus
doses
35.5%
(95%
CI
2.0,
57.5).
provided
higher
level
protection,
60.2%
22.8,
79.5)
15-180
days
vaccination,
this
VE
decreased
35.0%
2.8,
56.5)
180
days.
Evidence
detected
young
aged
18-39
years,
not
those
40
years
or
older.The
receipt
associated
significantly
lower
risk,
our
findings
confirmed
variants.
Given
rapid
evolution
SARS-CoV-2,
we
highlight
importance
continuously
monitoring
protective
performance
genetic
variants
regardless
existing
coverage.
International Journal of Environmental Research and Public Health,
Год журнала:
2022,
Номер
19(23), С. 16010 - 16010
Опубликована: Ноя. 30, 2022
Although
many
studies
of
long
COVID-19
were
reported,
there
was
a
lack
systematic
research
which
assessed
the
differences
in
regard
to
what
unique
SARS-CoV-2
strains
caused
it.
As
such,
this
review
and
meta-analysis
aims
evaluate
characteristics
that
is
by
different
strains.
We
systematically
searched
PubMed,
EMBASE,
ScienceDirect
databases
order
find
cohort
as
defined
WHO
(Geneva,
Switzerland).
The
main
outcomes
determining
percentages
among
patients
who
infected
with
Further,
study
registered
PROSPERO
(CRD42022339964).
A
total
51
33,573
included,
three
possessed
Alpha
Delta
variants,
five
Omicron
variant.
highest
pooled
estimate
found
CT
abnormalities
(60.5%;
95%
CI:
40.4%,
80.6%)
for
wild-type
strain;
fatigue
(66.1%;
42.2%,
89.9%)
variant;
≥1
general
symptoms
(28.4%;
7.9%,
49.0%)
estimates
(65.8%;
47.7%,
83.9%)
variant,
followed
strain,
then
myalgia
variant
(11.7%;
95%:
8.3%,
15.1%),
compared
those
strain
(9.4%;
6.3%,
12.5%).
sleep
difficulty
lowest
(2.5%;
0.2%,
4.9%)
when
(24.5%;
17.5%,
31.5%)
(18.7%;
1.0%,
36.5%).
findings
suggest
no
significant
difference
between
has
been
strains,
except
certain
(i.e.,
or
variant)
strain).
In
context
ongoing
pandemic
its
emerging
directing
more
attention
well
implementing
targeted
intervention
measures
address
it
are
vital.
BMJ Medicine,
Год журнала:
2023,
Номер
2(1), С. e000468 - e000468
Опубликована: Ноя. 1, 2023
The
T
cell
memory
response
is
a
crucial
component
of
adaptive
immunity
responsible
for
limiting
or
preventing
viral
reinfection.
after
infection
with
the
SARS-CoV-2
virus
vaccination
broad,
and
spans
multiple
proteins
epitopes,
about
20
in
each
individual.
So
far
long
lasting
provides
high
level
cross
reactivity
hence
resistance
to
escape
by
variants
virus,
such
as
omicron
variant.
All
current
vaccine
regimens
tested
produce
robust
responses,
heterologous
will
probably
enhance
protective
responses
through
increased
breadth.
could
have
major
role
protecting
against
severe
covid-19
disease
rapid
clearance
early
presentation
presence
reactive
cells
might
this
protection.
likely
provide
ongoing
protection
admission
hospital
death,
development
pan-coronovirus
future
proof
new
pandemic
strains.
International Journal of Environmental Research and Public Health,
Год журнала:
2023,
Номер
20(3), С. 2150 - 2150
Опубликована: Янв. 25, 2023
The
Omicron
(B.1.1.529)
variant
of
the
severe
acute
respiratory
syndrome
Coronavirus
2
(SARS-CoV-2)
had
an
increased
rate
spreading
among
general
population.
Although
this
virus
mutation
resulted
in
milder
symptoms,
those
on
vulnerable
side
population
are
still
danger
developing
symptoms.
Thus,
systematic
review
focused
identifying
clinical
outcomes
older
age
patients
(>65)
that
hospitalized
with
SARS-CoV-2
variant.
research
was
conducted
using
four
electronic
databases
(PubMed,
Scopus,
Web
Science,
and
ProQuest
Central),
a
search
query
December
2022
comprised
duration
COVID-19
pandemic.
inclusion
criteria
(1)
than
65
years,
(2)
history
hospitalization
for
infection,
(3)
infection
B.1.1.529
initial
generated
295
articles,
out
which
six
were
included
review,
total
7398
patients.
main
findings
when
looking
at
elderly
population,
mortality
rates
remained
high.
This
is
because
people
more
have
comorbidities
interfere
virus’s
progress.
However,
there
inconsistency
rates,
since
data
reported
by
studies
different
selection
based
severity
infection.
no
statistically
significant
differences
found
between
unvaccinated
vaccinated
groups,
who
got
booster
doses
vaccination
lower
likelihood
serving
as
protective
factor
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 10, 2025
SUMMARY
The
long-term
effects
of
repeated
COVID-19
vaccinations
on
adaptive
immunity
remain
incompletely
understood.
Here,
we
conducted
a
comprehensive
three-year
longitudinal
study
examining
T
cell
and
antibody
responses
in
78
vaccinated
individuals
without
reported
symptomatic
infections.
We
observed
distinct
dynamics
Spike-specific
humoral
cellular
immune
across
multiple
vaccine
doses.
While
titers
incrementally
increased
stabilized
with
each
booster,
rapidly
plateaued,
maintaining
remarkable
stability
CD4+
CD8+
subsets.
Notably,
approximately
30%
participants
showed
reactivity
to
non-Spike
antigens,
consistent
asymptomatic
Single-cell
RNA
sequencing
revealed
diverse
landscape
phenotypes,
no
evidence
exhaustion
or
significant
functional
impairment.
However,
qualitative
changes
were
infection,
exhibiting
unique
immunological
characteristics,
including
frequencies
Th17-like
cells
GZMKhi/IFNR
Remarkably,
this
group
associated
progressive
increase
regulatory
cells,
potentially
indicating
balanced
response
that
may
mitigate
immunopathology.
By
regularly
stimulating
memory,
boosters
contribute
stable
enhanced
response,
which
provide
better
protection
against
Journal of Medical Virology,
Год журнала:
2022,
Номер
95(1)
Опубликована: Ноя. 1, 2022
With
the
continued
spread
of
COVID-19
globally,
it
is
crucial
to
identify
potential
risk
or
protective
factors
associated
with
COVID-19.
Here,
we
performed
genetic
correlation
analysis
and
Mendelian
randomization
examine
relationships
between
hospitalization
405
health
conditions
lifestyle
in
456
422
participants
from
UK
Biobank.
The
revealed
134
positive
65
negative
correlations,
including
those
intakes
a
variety
dietary
components.
MR
indicates
that
set
body
fat-related
traits,
maternal
smoking
around
birth,
basal
metabolic
rate,
lymphocyte
count,
peripheral
enthesopathies
allied
syndromes,
blood
clots
leg,
arthropathy
are
causal
for
severe
COVID-19,
while
higher
education
attainment,
physical
activity,
asthma,
never
status
protect
against
illness.
Our
findings
have
implications
stratification
patients
prevention
its
outcomes.
JAMA Network Open,
Год журнала:
2023,
Номер
6(6), С. e2316190 - e2316190
Опубликована: Июнь 1, 2023
Importance
Children’s
role
in
spreading
virus
during
the
COVID-19
pandemic
is
yet
to
be
elucidated,
and
measuring
household
transmission
traditionally
requires
contact
tracing.
Objective
To
discern
children’s
viral
when
enveloped
viruses
were
at
historic
lows
predominance
of
illnesses
attributed
COVID-19.
Design,
Setting,
Participants
This
cohort
study
a
voluntary
US
tracked
data
from
participatory
surveillance
using
commercially
available
thermometers
with
companion
smartphone
app
October
2019
2022.
Eligible
participants
individuals
temperature
measurements
households
multiple
members
between
2022
who
opted
into
sharing.
Main
Outcomes
Measures
Proportion
transmissions
pediatric
index
case
changes
school
breaks
assessed
thermometer
data.
Results
A
total
862
577
320
073
(462
000
female
[53.6%]
463
368
adults
[53.7%])
included.
The
number
febrile
episodes
forecast
new
cases.
Within-household
was
inferred
54
506
(15.4%)
increased
fourth
period,
March
July
2021
(3263
32
294
[10.1%])
Omicron
BA.1/BA.2
wave
(16
516
94
316
[17.5%];
P
<
.001).
Among
38
787
166
170
children,
median
(IQR)
70.4%
(61.4%-77.6%)
had
case;
proportions
fluctuated
weekly
36.9%
84.6%.
0.6
0.8
times
less
frequent
typical
breaks.
winter
break
decrease
68.4%
(95%
CI,
57.1%-77.8%)
41.7%
34.3%-49.5%)
end
2020
(
At
beginning
2022,
it
dropped
80.3%
75.1%-84.6%)
54.5%
51.3%-57.7%)
During
summer
breaks,
rates
81.4%
74.0%-87.1%)
62.5%
56.3%-68.3%)
by
August
=
.02)
83.8%
79.2%-87.5)
62.8%
57.1%-68.1%)
These
patterns
persisted
over
2
years.
Conclusions
Relevance
In
this
measure
within-household
national
scale,
we
discerned
an
important
for
children
spread
infection
within
pandemic,
heightened
schools
session,
supporting
attendance
spread.
Emerging Microbes & Infections,
Год журнала:
2023,
Номер
12(2)
Опубликована: Сен. 11, 2023
Coronavirus
disease
2019
(COVID-19)
cases
in
China
has
grown
rapidly
after
adjustment
of
the
dynamic
zero-COVID-19
strategy.
However,
how
different
vaccination
states
affect
symptoms,
severity
and
post
COVID
conditions
was
unclear.
Here,
we
used
an
online
questionnaire
to
investigate
infection
status
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
among
11,897
participants,
with
55.55%
positive
28.42%
negative.
The
common
COVID-19
symptoms
were
fatigue
(73.31%),
cough
(70.02%),
fever
(65.25%)
overall
soreness
(58.64%);
self-reported
asymptomatic
accounted
for
0.7%
participants.
persistent
at
1
month
included
(48.7%),
drowsiness
(34.3%),
(30.1%),
decreased
exercise
ability
(23.1%)
pharyngeal
discomfort
(19.4%),
which
reduced
by
more
than
200%
months.
Participants
complications
such
as
chronic
obstructive
pulmonary
disease,
diseases,
diabetes,
hypertension,
etc.
have
a
higher
proportion
hospitalization
longer
recovery
time
(
Human Vaccines & Immunotherapeutics,
Год журнала:
2023,
Номер
19(1)
Опубликована: Янв. 2, 2023
Messenger
RNA
(mRNA)-based
vaccine
platforms
used
for
the
development
of
mRNA-1273
and
BNT162b2
have
provided
a
robust
adaptable
approach
to
offer
protection
against
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
However,
as
variants
concern
(VoCs),
such
omicron
associated
sub-variants,
emerge,
boosting
strategies
must
also
adapt
keep
pace
with
changing
landscape.
Heterologous
vaccination
regimens
involving
administration
booster
vaccines
different
than
primary
series
practical,
effective,
safe
continue
reduce
global
burden
disease
2019
(COVID-19).
To
understand
immunogenicity,
effectiveness,
safety
heterologous
mRNA-based
strategies,
relevant
clinical
real-world
observational
studies
were
identified
summarized.
Overall,
that
are
currently
available
those
in
will
play
an
important
role
protecting
individuals
from
COVID-19
caused
by
emerging
VoCs.